X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mogamulizumab (115) 115
index medicus (67) 67
humans (50) 50
oncology (46) 46
lymphomas (38) 38
t cells (38) 38
hematology (37) 37
lymphoma (36) 36
leukemia (34) 34
leukemia-lymphoma (31) 31
chemotherapy (28) 28
leukemia/lymphoma (28) 28
transplantation (27) 27
cancer (26) 26
female (26) 26
male (26) 26
kw-0761 (25) 25
monoclonal antibodies (25) 25
expression (24) 24
middle aged (24) 24
aged (23) 23
leukemia-lymphoma, adult t-cell - drug therapy (22) 22
ccr4 (21) 21
antibodies, monoclonal, humanized - therapeutic use (20) 20
medicine & public health (20) 20
multicenter phase-ii (20) 20
lymphocytes t (19) 19
adult t-cell leukemia/lymphoma (18) 18
anti-ccr4 antibody (18) 18
lymphocytes (18) 18
phase-ii (17) 17
non-hodgkin's lymphomas (16) 16
monoclonal-antibody kw-0761 (15) 15
patients (15) 15
antibodies, monoclonal, humanized - adverse effects (14) 14
immunotherapy (14) 14
sezary-syndrome (14) 14
t-cell lymphoma (14) 14
adult (13) 13
antibody (13) 13
atl (13) 13
brentuximab vedotin (13) 13
hematopoietic stem cells (13) 13
hemic and lymphatic diseases (13) 13
mycosis-fungoides (13) 13
analysis (12) 12
survival (12) 12
antibodies, monoclonal, humanized - administration & dosage (11) 11
dermatology (11) 11
immunology (11) 11
pharmacology & pharmacy (11) 11
prognosis (11) 11
receptors, ccr4 - antagonists & inhibitors (11) 11
stem cells (11) 11
versus-host-disease (11) 11
adult t-cell leukemia (10) 10
antibodies (10) 10
cc chemokine receptor 4 (10) 10
cutaneous t-cell lymphoma (10) 10
leukemia-lymphoma, adult t-cell - pathology (10) 10
medical prognosis (10) 10
mycosis fungoides (10) 10
receptors, ccr4 - immunology (10) 10
adult t-cell leukemia-lymphoma (9) 9
animals (9) 9
anti-ccr4 monoclonal-antibody (9) 9
sezary syndrome (9) 9
treatment outcome (9) 9
aged, 80 and over (8) 8
antineoplastic agents - therapeutic use (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
care and treatment (8) 8
chemokines (8) 8
htlv-1 (8) 8
infection (8) 8
japan (8) 8
medicine, research & experimental (8) 8
peripheral t-cell lymphoma (8) 8
skin (8) 8
atll (7) 7
biotechnology & applied microbiology (7) 7
cytotoxicity (7) 7
health aspects (7) 7
medical colleges (7) 7
open-label (7) 7
prognostic index (7) 7
prognostic-factors (7) 7
retrospective studies (7) 7
romidepsin (7) 7
stem cell transplantation (7) 7
therapy (7) 7
toxicity (7) 7
viral antibodies (7) 7
biological products (6) 6
combination chemotherapy (6) 6
fungal infections (6) 6
hematopoietic stem cell transplantation (6) 6
immunohistochemistry (6) 6
leukemia-lymphoma, adult t-cell - therapy (6) 6
medicine, general & internal (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Ring, J
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 01/2019, Volume 33, Issue 1, pp. 7 - 10
Journal Article
Japanese Journal of Clinical Pharmacology and Therapeutics, ISSN 0388-1601, 2018, Volume 49, Issue 2, pp. 87 - 90
Journal Article
Internal Medicine, ISSN 0918-2918, 2017
Mogamulizumab is a defucosylated humanized anti-CC chemokine receptor type 4 (CCR4) antibody that exerts an anti-tumor immune effect against various tumors... 
PTCL-NOS | mogamulizumab | EBV | secondary malignancy | CNS DLBCL
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2017, Volume 127, Issue 3, pp. 801 - 813
Elevated expression of the chemokine receptor CCR4 in tumors is associated with poor prognosis in several cancers. Here, we have determined that CCR4 was... 
MEDICINE, RESEARCH & EXPERIMENTAL | RECRUITMENT | CHEMOKINE RECEPTOR 4 | MULTICENTER PHASE-II | REGULATORY T-CELLS | LYMPHOMA | MOGAMULIZUMAB | MACROPHAGE POLARIZATION | EXPRESSION | CARCINOMA | PROGRESSION | Receptors, CCR4 - immunology | Humans | Neoplasm Proteins - immunology | Carcinoma, Renal Cell - genetics | Chemokine CCL17 - genetics | Male | Neoplasm Proteins - antagonists & inhibitors | Th1 Cells - immunology | Carcinoma, Renal Cell - immunology | Antibodies, Neoplasm - pharmacology | Tumor Microenvironment - genetics | Neoplasms, Experimental - immunology | Chemokine CCL17 - immunology | Neoplasms, Experimental - genetics | Killer Cells, Natural - immunology | Chemokine CCL17 - pharmacology | Female | Interferon-gamma - genetics | Carcinoma, Renal Cell - drug therapy | Neoplasm Proteins - genetics | Tumor Microenvironment - drug effects | Kidney Neoplasms | Antibodies, Neoplasm - immunology | Receptors, CCR4 - genetics | Receptors, CCR4 - antagonists & inhibitors | Tumor Microenvironment - immunology | Animals | Interferon-gamma - immunology | Mice | Mice, Inbred BALB C | Neoplasms, Experimental - drug therapy | Antagonists (Biochemistry) | Genetic aspects | Carcinoma, Renal cell | Research | Gene expression | Medical research | Plasma | Leukemia | Melanoma | Breast cancer | Experiments | Patients | Ovarian cancer | Studies | Design | Genotype & phenotype | Biopsy | Lymphocytes | Medical prognosis | Kidney cancer | Ligands | Software | Lymphomas | Chemokines
Journal Article
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 2019, Volume 54, Issue 9, pp. 1399 - 1405
A dose-intensified multi-agent chemotherapy regimen called VCAP-AMP-VECP was investigated in Japan as front-line therapy for patients with adult T-cell... 
PROGNOSTIC INDEX | ONCOLOGY | LEUKEMIA/LYMPHOMA | IMMUNOLOGY | MOGAMULIZUMAB | COMBINATION | HEMATOLOGY | TRANSPLANTATION | Chemotherapy | Multiagent systems | AMP | Risk groups | Leukemia | Risk | Lymphomas | Lymphocytes T | Lymphoma
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2015, Volume 47, Issue 12, pp. 1426 - 1434
Journal Article
Cancer treatment and research, ISSN 0927-3042, 2019, Volume 176, pp. 145 - 161
Adult T-cell leukemia-lymphoma (ATL) is a peripheral T-lymphocyte malignancy caused by an RNA retrovirus, human T-cell leukemia virus type 1. ATL is clinically... 
ATL | Mogamulizumab | Lenalidomide | CCR4 | Adult T-cell leukemia-lymphoma | Index Medicus
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 5, pp. 672 - 682
Summary This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐CC chemokine receptor 4... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | adult T-cell leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | RECEPTOR | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | ASSOCIATION | TRANSPLANTATION | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Haematological Malignancy | Research Paper
Journal Article
by Kim, Ellen J and Kim, Youn H and Bagot, Martine and Pinter-Brown, Lauren and Rook, Alain H and Porcu, Pierluigi and Horwitz, Steven M and Whittaker, Sean and Tokura, Yoshiki and Vermeer, Maarten and Zinzani, Pier Luigi and Sokol, Lubomir and Morris, Stephen and Ortiz-Romero, Pablo L and Eradat, Herbert and Scarisbrick, Julia and Tsianakas, Athanasios and Elmets, Craig and Dalle, Stephane and Fisher, David C and Halwani, Ahmad and Poligone, Brian and Greer, John and Fierro, Maria Teresa and Khot, Amit and Moskowitz, Alison J and Musiek, Amy and Shustov, Andrei and Pro, Barbara and Geskin, Larisa J and Dwyer, Karen and Moriya, Junji and Leoni, Mollie and Humphrey, Jeffrey S and Hudgens, Stacie and Grebennik, Dmitri O and Tobinai, Kensei and Duvic, Madeleine and Abhyankar, Sunil and Akilov, Oleg and Alpdogan, Onder and Beylot-Barry, Marie and Boh, Erin and Caballero, Dolores and Cowan, Richard and Dreno, Brigitte and Dummer, Reinhard and Fenske, Timothy and Foss, Francine and Fukuhara, Noriko and Giri, Pratyush and Habe, Koji and Hamada, Toshihisa and Hatake, Kiyohiko and Iida, Shinsuke and Ishikawa, Osamu and Iversen, Lars and Kiyohara, Eiji and Koga, Hiroshi and Korman, Neil and Kuss, Bryone Jean and Lamar, Zanetta and Lansigan, Frederick and Lechowicz, Mary Jo and Lerner, Adam and Magnolo, Nina and Mark, Lawrence and Miyagaki, Tomomitsu and Munoz, Javier and Nicolay, Jan Peter and Nishiwaki, Kaoru and Okamoto, Hiroyuki and Ohtsuka, Mikio and Pacheco, Theresa and Querfeld, Christiane and Rapini, Ronald Peter and Sano, Shigetoshi and Tanaka, Maiko and Tharp, Michael D and Uehara, Jiro and Wada, Hidefumi and Wells, Jillian and Wilcox, Ryan A and William, Basem and Yonekura, Kentaro and MAVORIC Investigators
The Lancet Oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1192 - 1204
Journal Article
CLINICAL JOURNAL OF ONCOLOGY NURSING, ISSN 1092-1095, 08/2019, Volume 23, Issue 4, pp. E73 - E80
BACKGROUND: Cutaneous T-cell lymphoma (CTCL), including subtypes mycosis fungoides (MF) and Sezary syndrome (SS), represents a rare group of non-Hodgkin... 
UNITED-STATES | mogamulizumab | NURSING | MYCOSIS-FUNGOIDES | adverse events | SEZARY-SYNDROME | mycosis fungoides | CONSORTIUM | Sezary syndrome | CCR4 EXPRESSION | ONCOLOGY | KW-0761 | LEUKEMIA
Journal Article